Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 28 symbols : SNYNF save search
COVID-19 Vaccine Update: Data on Younger Children and mRNA Program Dropped
Published: 2021-09-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
covid drop children vaccine covid-19
Psychiatry on the Brink: Precision Medicine Finally Streamlines Therapeutic Selection
Published: 2021-09-28 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
therapeutics
FDA Accepts Libtayo® (cemiplimab-rwlc) for Priority Review for Advanced Cervical Cancer
Published: 2021-09-28 (Crawled : 12:15) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -1.91%
H: 1.73%
C: -0.37%
fda cancer fda acceptance
Psychiatry on the Brink: Precision Medicine Finally Streamlines Therapeutic S...
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
therapeutics
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.15%
H: 0.49%
C: -0.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -4.36%
H: 1.09%
C: -5.85%
covid fda children vaccine trial
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 0.35%
H: 2.45%
C: -4.9%
ANAB | $19.865 0.18% 0.18% 290K
|
Health Technology
|
| O: -1.15%
H: 1.05%
C: 0.56%
ATNM | $6.85 2.7% 0.0% 350K
|
Health Technology
|
| O: -1.14%
H: 1.36%
C: -3.14%
technology
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
Published: 2021-09-28 (Crawled : 10:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.05%
H: 0.24%
C: -2.8%
commercialization pharma
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate
Published: 2021-09-28 (Crawled : 07:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
phase 1 positive results vaccine phase 2 phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.